Visionary Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Visionary Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-7,671	Closed	-$667K	–	89
2016 Q1	$667K	Sell	7,671 -1,824	-19%	-$163K	0.24%	77
2015 Q4	$1.07M	Buy	9,495 +3,615	+61%	+$392K	0.73%	16
2015 Q3	$595K	Buy	5,880 +2,586	+79%	+$310K	0.43%	20
2015 Q2	$405K	Buy	+3,294	New	+$394K	0.14%	92
2015 Q1	–	Sell	-186	Closed	-$19K	–	140
2014 Q4	$19K	Buy	+186	New	+$18.1K	0.01%	126

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Visionary Asset Management's IBB Position: Q2 2016 in Review

Visionary Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 7,671 shares — an estimated $667K sold.

Visionary Asset Management first reported a position in IBB in Q4 2014 and held it in 5 quarters. The position peaked at $1.07M in Q4 2015. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

Visionary Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
Visionary Asset Management sold 7,671 iShares Biotechnology ETF shares in Q2 2016, an estimated $667K.
Visionary Asset Management first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 5 quarters.
Visionary Asset Management's iShares Biotechnology ETF position peaked at $1.07M in Q4 2015.
428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Visionary Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.